New study shows better biomarkers for MSI mCRC
This transcript has been edited for clarity. I’m David Kerr, Professor of Cancer Medicine at the University of Oxford.Today I would like to talk about the following A really great paper published earlier this year Oncology annual report By an excellent French group. As you know, we have always had a strong interest in precision […]
Maximal tumor debulking with systemic therapy does not affect QoL in mCRC
Colorectal cancer, medical illustration 3D illustration: © Anatomy Insider – Stock.adobe.com Results from ORCHESTRA’s prespecified exploratory analysis show that even the addition of maximal tumor debulking to standard systemic therapy is associated with lower risk of cancer in patients with metastatic colorectal cancer (mCRC) compared to systemic therapy alone. trial (NCT01792934) that had no significant […]